off
Hikma Pharmaceuticals acquires US labs in $2.25bn deal
London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector’s latest rapid round of consolidation.
Posted On Jul 28 2015
